甲状旁腺激素类似物对骨折愈合疗效的荟萃分析
该荟萃分析纳入成人急性骨折的前瞻性随机对照试验,评估甲状旁腺激素(PTH)类似物对骨折愈合的疗效。结果显示PTH类似物改善功能结局,但不影响骨折愈合率或减轻疼痛,且无证据表明其造成伤害或阻碍骨折愈合。
要点
- PTH类似物可改善多种骨折类型的功能结局。
- PTH类似物未提高骨折愈合率或减轻疼痛。
- 多数试验纳入老年骨质疏松患者,年轻非骨质疏松人群证据不足。
核心结论
- PTH类似物治疗可改善功能结局,但不影响骨折愈合率或疼痛。
- 无证据表明PTH治疗造成伤害或阻碍骨折愈合。
研究设计与样本
- 系统检索MEDLINE、EMBASE和Cochrane Library(2019年8月),无日期限制。
- 纳入成人急性骨折接受PTH类似物治疗的随机对照试验,对照为安慰剂、无治疗或其他干预。
主要发现
- PTH类似物改善多种骨折类型的功能结局。
- PTH类似物未影响骨折愈合率或减轻疼痛。
- 多数试验纳入老年骨质疏松患者。
临床怎么用
- 可考虑使用PTH类似物改善骨折患者功能结局,但不应期望提高愈合率或减轻疼痛。
局限性
- 试验设计异质性大且质量有限,需进一步原创试验。
- 年轻非骨质疏松人群证据不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This meta-analysis evaluated the evidence for the use of parathyroid hormone (PTH) analogues to improve fracture healing. Eligible studies were prospective randomised controlled trials of adults with acute fractures treated with a PTH analogue. PTH improved functional outcomes but did not affect fracture healing rate or reduce pain. PURPOSE: This meta-analysis evaluated the evidence of parathyroid hormone (PTH) analogues in fracture healing. The use of PTH analogues to prevent osteoporotic fractures is well investigated, and studies are emerging on extended indications. One such indication receiving increasing attention is the effect of PTH in fracture healing; however, the overall degree of efficacy remains inconclusive. METHODS: A systematic electronic database search of MEDLINE, EMBASE and the Cochrane Library was conducted for relevant articles in August 2019 with no date restrictions. Randomised controlled trials of adults with acute fractures treated with a PTH analogue were included. PTH was compared with a comparator intervention, placebo or no treatment. RESULTS: PTH analogue treatment improved functional outcomes in a range of fracture types but did not affect the fracture healing rate or reduce pain. Most trials included in this review were in elderly patients with osteoporosis. There was no evidence that PTH treatment caused harm or impeded fracture healing. CONCLUSIONS: Meta-analysis of published data supports the use of PTH analogues to improve functional outcomes but not fracture healing rate or pain for different fracture types. The evidence for PTH analogue use in fracture healing is less clear in younger, non-osteoporotic patient populations. Trial design was heterogeneous and of limited quality, justifying further original trials.
引用
- Eastman K, Gerlach M, Piec I, et al. Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis. Osteoporos Int. 2021. PMID: 33559713. doi:10.1007/s00198-021-05847-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。